MaxLinear Total Liab vs Capital Stock Analysis
MXL Stock | USD 19.39 0.05 0.26% |
MaxLinear financial indicator trend analysis is infinitely more than just investigating MaxLinear recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MaxLinear is a good investment. Please check the relationship between MaxLinear Total Liab and its Capital Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxLinear. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy MaxLinear Stock please use our How to buy in MaxLinear Stock guide.
Total Liab vs Capital Stock
Total Liab vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MaxLinear Total Liab account and Capital Stock. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between MaxLinear's Total Liab and Capital Stock is 0.42. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Stock in the same time period over historical financial statements of MaxLinear, assuming nothing else is changed. The correlation between historical values of MaxLinear's Total Liab and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of MaxLinear are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Total Liab i.e., MaxLinear's Total Liab and Capital Stock go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most indicators from MaxLinear's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MaxLinear current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxLinear. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy MaxLinear Stock please use our How to buy in MaxLinear Stock guide.At this time, MaxLinear's Tax Provision is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 5.6 M this year, although the value of Sales General And Administrative To Revenue will most likely fall to 0.28.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 495.8M | 649.8M | 385.7M | 199.3M | Total Revenue | 892.4M | 1.1B | 693.3M | 361.0M |
MaxLinear fundamental ratios Correlations
Click cells to compare fundamentals
MaxLinear Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MaxLinear fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 705.8M | 1.0B | 1.1B | 1.2B | 1.1B | 1.1B | |
Short Long Term Debt Total | 216.2M | 384.5M | 330.8M | 155.6M | 157.8M | 145.4M | |
Other Current Liab | 47.4M | 191.6M | 139.4M | 260.6M | 185.9M | 195.2M | |
Total Current Liabilities | 66.6M | 233.7M | 207.4M | 341.1M | 222.1M | 233.2M | |
Total Stockholder Equity | 414.9M | 391.1M | 489.2M | 676.4M | 686.3M | 720.6M | |
Property Plant And Equipment Net | 27.6M | 61.4M | 88.2M | 107.5M | 97.7M | 102.6M | |
Current Deferred Revenue | 939K | 1.2M | 6.2M | 1.4M | 5.6M | 3.1M | |
Net Debt | 123.5M | 235.6M | 200.2M | (31.8M) | (29.5M) | (28.1M) | |
Retained Earnings | (113.8M) | (212.4M) | (170.4M) | (45.4M) | (118.5M) | (124.5M) | |
Accounts Payable | 13.4M | 32.8M | 53.0M | 68.6M | 21.6M | 17.6M | |
Cash | 92.7M | 148.9M | 130.6M | 187.4M | 187.3M | 196.7M | |
Non Current Assets Total | 524.0M | 660.7M | 646.3M | 616.9M | 592.2M | 303.4M | |
Non Currrent Assets Other | 2.8M | 2.2M | 3.7M | 15M | 21.0M | 22.1M | |
Cash And Short Term Investments | 92.7M | 148.9M | 130.6M | 205.9M | 187.3M | 101.1M | |
Net Receivables | 50.4M | 67.4M | 119.7M | 171.0M | 170.6M | 179.1M | |
Common Stock Shares Outstanding | 71.0M | 73.1M | 79.7M | 80.9M | 80.7M | 55.7M | |
Liabilities And Stockholders Equity | 705.8M | 1.0B | 1.1B | 1.2B | 1.1B | 1.1B | |
Non Current Liabilities Total | 224.3M | 397.7M | 353.8M | 162.6M | 171.9M | 132.6M | |
Inventory | 31.5M | 97.8M | 131.7M | 160.5M | 99.9M | 104.9M | |
Other Current Assets | 7.1M | 7.0M | 9.8M | 25.7M | 29.2M | 30.6M | |
Other Stockholder Equity | 529.6M | 602.1M | 657.5M | 722.8M | 808.6M | 849.0M | |
Total Liab | 290.9M | 631.3M | 561.2M | 503.6M | 394.0M | 228.9M | |
Property Plant And Equipment Gross | 27.6M | 61.4M | 88.2M | 107.5M | 213.9M | 224.6M | |
Total Current Assets | 181.8M | 361.7M | 404.1M | 563.1M | 488.0M | 512.4M | |
Accumulated Other Comprehensive Income | (887K) | 1.4M | 2.1M | (1.0M) | (3.8M) | (3.6M) | |
Short Term Debt | 4.8M | 8.1M | 8.9M | 10.5M | 9.1M | 8.5M | |
Other Assets | 70.1M | 111.2M | 98.9M | 81.5M | 93.7M | 98.4M | |
Long Term Debt | 206.9M | 363.6M | 306.2M | 121.8M | 122.4M | 118.6M | |
Property Plant Equipment | 16.6M | 39.5M | 88.2M | 79.0M | 90.9M | 95.4M | |
Other Liab | 8.1M | 13.2M | 23.0M | 17.4M | 20.1M | 21.1M | |
Intangible Assets | 188.0M | 207.3M | 152.5M | 109.3M | 73.6M | 114.7M | |
Net Tangible Assets | (11.4M) | (119.0M) | 30.0M | 260.3M | 234.3M | 246.0M | |
Retained Earnings Total Equity | (113.8M) | (212.4M) | (170.4M) | (45.4M) | (40.8M) | (42.9M) | |
Long Term Debt Total | 206.9M | 363.6M | 306.2M | 121.8M | 140.0M | 251.7M | |
Capital Surpluse | 529.6M | 602.1M | 657.5M | 722.8M | 831.2M | 445.7M | |
Capital Lease Obligations | 14.1M | 20.9M | 33.5M | 33.8M | 35.4M | 37.1M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as MaxLinear using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MaxLinear. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy MaxLinear Stock please use our How to buy in MaxLinear Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for MaxLinear Stock analysis
When running MaxLinear's price analysis, check to measure MaxLinear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxLinear is operating at the current time. Most of MaxLinear's value examination focuses on studying past and present price action to predict the probability of MaxLinear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxLinear's price. Additionally, you may evaluate how the addition of MaxLinear to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is MaxLinear's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MaxLinear. If investors know MaxLinear will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MaxLinear listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share (1.91) | Revenue Per Share 6.632 | Quarterly Revenue Growth (0.62) | Return On Assets (0.06) |
The market value of MaxLinear is measured differently than its book value, which is the value of MaxLinear that is recorded on the company's balance sheet. Investors also form their own opinion of MaxLinear's value that differs from its market value or its book value, called intrinsic value, which is MaxLinear's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MaxLinear's market value can be influenced by many factors that don't directly affect MaxLinear's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MaxLinear's value and its price as these two are different measures arrived at by different means. Investors typically determine if MaxLinear is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MaxLinear's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.